694 related articles for article (PubMed ID: 24954652)
1. Uptake of noninvasive prenatal testing at a large academic referral center.
Larion S; Warsof SL; Romary L; Mlynarczyk M; Peleg D; Abuhamad AZ
Am J Obstet Gynecol; 2014 Dec; 211(6):651.e1-7. PubMed ID: 24954652
[TBL] [Abstract][Full Text] [Related]
2. The impact of noninvasive prenatal testing on the practice of maternal-fetal medicine.
Friel LA; Czerwinski JL; Singletary CN
Am J Perinatol; 2014 Oct; 31(9):759-64. PubMed ID: 24338115
[TBL] [Abstract][Full Text] [Related]
3. Association of combined first-trimester screen and noninvasive prenatal testing on diagnostic procedures.
Larion S; Warsof SL; Romary L; Mlynarczyk M; Peleg D; Abuhamad AZ
Obstet Gynecol; 2014 Jun; 123(6):1303-1310. PubMed ID: 24807333
[TBL] [Abstract][Full Text] [Related]
4. Women's views and the impact of noninvasive prenatal testing on procedures in a managed care setting.
Tiller GE; Kershberg HB; Goff J; Coffeen C; Liao W; Sehnert AJ
Prenat Diagn; 2015 May; 35(5):428-33. PubMed ID: 25201151
[TBL] [Abstract][Full Text] [Related]
5. Invasive prenatal diagnostic practice in Denmark 1996 to 2006.
Vestergaard CH; Lidegaard Ø; Tabor A
Acta Obstet Gynecol Scand; 2009; 88(3):362-5. PubMed ID: 19172424
[TBL] [Abstract][Full Text] [Related]
6. The role of noninvasive prenatal testing as a diagnostic versus a screening tool--a cost-effectiveness analysis.
Ohno M; Caughey A
Prenat Diagn; 2013 Jul; 33(7):630-5. PubMed ID: 23674316
[TBL] [Abstract][Full Text] [Related]
7. Utilization of noninvasive prenatal testing: impact on referrals for diagnostic testing.
Williams J; Rad S; Beauchamp S; Ratousi D; Subramaniam V; Farivar S; Pisarska MD
Am J Obstet Gynecol; 2015 Jul; 213(1):102.e1-102.e6. PubMed ID: 25882918
[TBL] [Abstract][Full Text] [Related]
8. Use of the Combined First-Trimester Screen in High- and Low-Risk Patient Populations After Introduction of Noninvasive Prenatal Testing.
Larion S; Warsof SL; Romary L; Mlynarczyk M; Peleg D; Abuhamad AZ
J Ultrasound Med; 2015 Aug; 34(8):1423-8. PubMed ID: 26206828
[TBL] [Abstract][Full Text] [Related]
9. Declining invasive prenatal diagnostic procedures: A comparison of tertiary hospital and national data from 2012 to 2015.
Johnson K; Kelley J; Saxton V; Walker SP; Hui L
Aust N Z J Obstet Gynaecol; 2017 Apr; 57(2):152-156. PubMed ID: 28295165
[TBL] [Abstract][Full Text] [Related]
10. Prenatal screening for Down syndrome in Australia: costs and benefits of current and novel screening strategies.
O'Leary P; Maxwell S; Murch A; Hendrie D
Aust N Z J Obstet Gynaecol; 2013 Oct; 53(5):425-33. PubMed ID: 24090461
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive prenatal testing: impact on genetic counseling, invasive prenatal diagnosis, and trisomy 21 detection.
Wax JR; Cartin A; Chard R; Lucas FL; Pinette MG
J Clin Ultrasound; 2015 Jan; 43(1):1-6. PubMed ID: 25303161
[TBL] [Abstract][Full Text] [Related]
12. Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening.
Chetty S; Garabedian MJ; Norton ME
Prenat Diagn; 2013 Jun; 33(6):542-6. PubMed ID: 23592525
[TBL] [Abstract][Full Text] [Related]
13. A new era in prenatal care: non-invasive prenatal testing in Switzerland.
Manegold-Brauer G; Kang Bellin A; Hahn S; De Geyter C; Buechel J; Hoesli I; Lapaire O
Swiss Med Wkly; 2014 Feb; 144():w13915. PubMed ID: 24549748
[TBL] [Abstract][Full Text] [Related]
14. The consequences of implementing non-invasive prenatal testing in Dutch national health care: a cost-effectiveness analysis.
Beulen L; Grutters JP; Faas BH; Feenstra I; van Vugt JM; Bekker MN
Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():53-61. PubMed ID: 25238658
[TBL] [Abstract][Full Text] [Related]
15. Utilization of available prenatal screening and diagnosis: effects of the California screen program.
Blumenfeld YJ; Taylor J; Lee HC; Hudgins L; Sung JF; El-Sayed YY
J Perinatol; 2012 Dec; 32(12):907-12. PubMed ID: 22402484
[TBL] [Abstract][Full Text] [Related]
16. The impact of utilization of early aneuploidy screening on amniocenteses available for training in obstetrics and fetal medicine.
Rose NC; Lagrave D; Hafen B; Jackson M
Prenat Diagn; 2013 Mar; 33(3):242-4. PubMed ID: 23354826
[TBL] [Abstract][Full Text] [Related]
17. Potential diagnostic consequences of applying non-invasive prenatal testing: population-based study from a country with existing first-trimester screening.
Petersen OB; Vogel I; Ekelund C; Hyett J; Tabor A; ;
Ultrasound Obstet Gynecol; 2014 Mar; 43(3):265-71. PubMed ID: 24375770
[TBL] [Abstract][Full Text] [Related]
18. Chorionic Villus Sampling, Early Amniocentesis, and Termination of Pregnancy Without Diagnostic Testing: Comparison of Fetal Risk Following Positive Non-invasive Prenatal Testing.
Zelig CM; Knutzen DM; Ennen CS; Dolinsky BM; Napolitano PG
J Obstet Gynaecol Can; 2016 May; 38(5):441-445.e2. PubMed ID: 27261219
[TBL] [Abstract][Full Text] [Related]
19. Changes in the utilization of prenatal diagnosis.
Benn PA; Egan JF; Fang M; Smith-Bindman R
Obstet Gynecol; 2004 Jun; 103(6):1255-60. PubMed ID: 15172861
[TBL] [Abstract][Full Text] [Related]
20. Impact of first-trimester aneuploidy screening in a high-risk population.
Nadel AS; Likhite ML
Fetal Diagn Ther; 2009; 26(1):29-34. PubMed ID: 19816027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
